Safety and Efficacy Study Using ABT-335 (Investigational Drug) in Combination With Atorvastatin, to Study the Effects on Thickening of the Blood Vessel Wall in Patients With Abnormal Lipid (Fat) Levels in the Blood
Study Identifier
M10-158
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete
Results Available
Scientific Result Summary
Available Language(s): English
Study Details
Medical Condition
Study Drug
Phase
Phase 3
Sex
Female & Male
Age
45+ years
Protocol Summary
The primary purpose of this study is to test the effect and safety of once daily ABT-335 on the thickness of the lining of the carotid artery (a blood vessel to the brain) in patients with abnormal blood lipids who have optimal levels of low density lipoprotein cholesterol ("bad cholesterol") after taking atorvastatin.
Study Locations
Location
Status
Location
Site Reference ID/Investigator# 6747
Chandler, Arizona, United States, 85225
Status
Not applicable
Location
Site Reference ID/Investigator# 7089
Gilbert, Arizona, United States, 85295
Status
Not applicable
Location
Site Reference ID/Investigator# 7097
Mesa, Arizona, United States, 85206
Status
Not applicable
Location
Site Reference ID/Investigator# 26394
Phoenix, Arizona, United States, 85032
Status
Not applicable
Location
Site Reference ID/Investigator# 6848
Scottsdale, Arizona, United States, 85251
Status
Not applicable
Location
Site Reference ID/Investigator# 7059
Tempe, Arizona, United States, 85282
Status
Not applicable
Showing {first} - {last} of {total} Results